Avanos Medical (AVNS) Assets Average (2014 - 2026)

Avanos Medical (AVNS) has 13 years of Assets Average data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 6.11% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 6.11% YoY), and the FY2025 full-year result was $1.1 billion, down 21.73% from the prior year.
• Assets Average retreated to $1.1 billion in Q1 2026, from $1.1 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.8 billion in Q4 2022 to a low of $1.1 billion in Q3 2025.
• A 5-year average of $1.5 billion and a median of $1.7 billion in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average increased 11.26% in 2022 and sank 36.43% in 2025, its largest moves.
• Tracing AVNS's Assets Average over 5 years: stood at $1.8 billion in 2022, then slipped by 4.07% to $1.7 billion in 2023, then fell by 17.76% to $1.4 billion in 2024, then retreated by 23.8% to $1.1 billion in 2025, then declined by 0.82% to $1.1 billion in 2026.
• Business Quant data shows AVNS's Assets Average at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.